Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

Tag: Suzhou

Robert Walters China Salary Survey 2023: Easing of Epidemic Control: Recruitment...

PR Newswire -

Commercialization of Gene Therapy is coming soon: Neurophth Completes Patient Enrollment...

PR Newswire -

Eluminex Biosciences Announces Completion of Initial Enrollment in Part A of...

PR Newswire -

Qiming Venture Partners’ portfolio company LanzaTech Lists on Nasdaq

PR Newswire -

Celebrate the Lantern Festival and Enjoy Lanterns in the Glittering Ancient...

PR Newswire -

Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq

PR Newswire -

Gracell Biotechnologies Announces FDA Clearance of the IND Application for Phase...

PR Newswire -

China’s First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into...

PR Newswire -

Village welcomes riches by developing tourism

PR Newswire -

Innovent Presents Phase 1b Clinical Data of IBI188 (Anti-CD47 Monoclonal Antibody)...

PR Newswire -

Gracell Biotechnologies Presents Clinical Data for FasTCAR-T GC012F for High Risk,...

PR Newswire -

ZEISS Makes Fifth Appearance at CIIE, Placing Great Effort in Localization...

PR Newswire -

Harbour BioMed Announces Dosing of First Patient in Phase I Trial...

PR Newswire -

Innovent Announces Phase Ib Results of Higher-dose Mazdutide (IBI362) in Chinese...

PR Newswire -

Sciwind Biosciences and SynerK Enter into Research Partnership to Discover and...

PR Newswire -

Admiring the Moon and Enjoying Mooncakes……Chinese Youth Preserving Romantic Festive Customs

PR Newswire -

The 2022 Yangtze River Culture Festival kicked off in Zhangjiagang

PR Newswire -

Ascentage Pharma Announces 2022 Interim Results

PR Newswire -

Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases

PR Newswire -

WuXi Biologics Reports Strong 2022 Interim Results

PR Newswire -

Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase...

PR Newswire -

Transcenta to Present Interim Safety and Efficacy Data of the TST001...

PR Newswire -

Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named...

PR Newswire -

China CDE Grants Breakthrough Therapy Designation (BTD) to Neurophth’s NR082 in...

PR Newswire -

CStone Announces the NDA Approval of GAVRETO® (pralsetinib) for the Treatment...

PR Newswire -

ASCO 2022 | Ascentage Pharma Releases Updated Data Demonstrating Lisaftoclax’s (APG-2575)...

PR Newswire -

ASCO 2022 | Ascentage Pharma Releases for the First Time Results...

PR Newswire -

CStone presents updated results of anti-PD-1 antibody nofazinlimab in combination with...

PR Newswire -

CStone presents clinical results of sugemalimab in patients with relapsed or...

PR Newswire -

Gracell Biotechnologies Schedules Clinical Update Call After EHA2022

PR Newswire -

Innovent Appoints Mr. Gary Zieziula as Independent Non-executive Director

PR Newswire -

Want to see more data? Registered subscribers can see all the data.

   Register Now!
Caishen.Co - Primary Data for China Secondary Investment and Stock Markets
© 2021 China Money Network Limited. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.